Madrigal Pharmaceuticals: a leader in MASH treatment with significant growth potential
Madrigal Pharmaceuticals $MDGL entered 2024 with significant success when it launched its first approved drug, Rezdiffra, for the treatment of metabolic steatohepatitis (MASH). This unique drug helps patients with moderate to advanced liver fibrosis, giving Madrigal a privileged position in a... Read more
I read now that Trump has appointed a new Health Secretary and he is not supporting and fighting against such companies, so we'll see how this plays out now.
🚀 Key events and company results in the coming week!
💊Monday: Results Before the markets open: Bayer $BAYN.DE: The German pharmaceutical and agrochemical giant reports its quarterly earnings. The results will be of interest not only to the pharmaceutical sector, but also to agriculture-oriented investors. CEZ $CEZ.PR: Important results for all CEZ shareholders. Continental $CON.... Read more
I'll be interested in that Thursday, and otherwise there are still plenty of interesting companies that will report their results, so maybe $SPOT, $DIS or $BABA.
This week is going to be very interesting again and probably a large part of the US stocks will still rise thanks to Trump's win. I'll be interested in the results of $CEZ.PR, $SPOT, $DIS and $BABAnext week + I'll definitely be watching how the price of $BTCUSD develops .
Which company's results will you be interested in this week?
AppLovin: Rocketing growth thanks to success in mobile app monetization
AppLovin Corp. $APP, a leading provider of mobile app monetization software, saw its stock rise an impressive 41% after posting third-quarter results that beat expectations. The jump reflects investors' positive view of the company's growth potential, fueled by its technological edge and strong position in... Read more
⚙️Arm exceeded expectations and achieved record Q2 results!
Arm $ARM on Wednesday released results for its second fiscal quarter ending September 30, 2024 - and the numbers are really hilarious! 📈💼
Arm Holdings is a British technology company focused on designing semiconductor chips and processors that power many different devices, from smartphones and tablets to servers in data... Read more
For me, a quality company that is in an important sector and overall I like the focus and would like to have this sector represented in my portfolio. So I'll either buy $LMT or $RHM.DE, but I'll have to wait a while for a better price as both stocks are still pretty expensive.
📈 CVS Health stock on the rise: strong results and changes in leadership!
CVS Health $CVS, one of America's largest providers of healthcare services and pharmacy products, posted strong quarterly results that beat analyst expectations. The result was a sharp rise in share value. The company's revenue increased by 6,3 % to an impressive $95.4 billion, while earnings per share... Read more
Madrigal Pharmaceuticals: a leader in MASH treatment with significant growth potential
Madrigal Pharmaceuticals $MDGL entered 2024 with significant success when it launched its first approved drug, Rezdiffra, for the treatment of metabolic steatohepatitis (MASH). This unique drug helps patients with moderate to advanced liver fibrosis, giving Madrigal a privileged position in a...
Read more
Zobrazit další komentáře
I read now that Trump has appointed a new Health Secretary and he is not supporting and fighting against such companies, so we'll see how this plays out now.
Bulios Black
This user has access to exclusive content, tools and features of the Bulios platform thanks to their subscription.
Hey, guys,
I'm holding a little bit of $2GB.DEstock and I'm wondering if I should sell when it's back to the buy price (+-10%).
...Read more
Zobrazit další komentáře
I probably wouldn't expect much from this company. Hands off.
3 high dividend yield stocks to watch
🚀 Key events and company results in the coming week!
💊Monday:
Results Before the markets open: Bayer $BAYN.DE: The German pharmaceutical and agrochemical giant reports its quarterly earnings. The results will be of interest not only to the pharmaceutical sector, but also to agriculture-oriented investors.
CEZ $CEZ.PR: Important results for all CEZ shareholders.
Continental $CON....
Read more
Zobrazit další komentáře
I'll be interested in that Thursday, and otherwise there are still plenty of interesting companies that will report their results, so maybe $SPOT, $DIS or $BABA.
This week is going to be very interesting again and probably a large part of the US stocks will still rise thanks to Trump's win. I'll be interested in the results of $CEZ.PR, $SPOT, $DIS and $BABAnext week + I'll definitely be watching how the price of $BTCUSD develops .
Which company's results will you be interested in this week?
Zobrazit další komentáře
I don't invest in China, but I saw that Alibaba has quite a bit of cash for buybacks right now, which is good news.
3 stocks that have recently increased their dividends
AppLovin: Rocketing growth thanks to success in mobile app monetization
AppLovin Corp. $APP, a leading provider of mobile app monetization software, saw its stock rise an impressive 41% after posting third-quarter results that beat expectations. The jump reflects investors' positive view of the company's growth potential, fueled by its technological edge and strong position in...
Read more
Zobrazit další komentáře
I don't know if such growth is sustainable in the long term, so I won't invest in it, but it's an interesting stock.
⚙️Arm exceeded expectations and achieved record Q2 results!
Arm $ARM on Wednesday released results for its second fiscal quarter ending September 30, 2024 - and the numbers are really hilarious! 📈💼
Arm Holdings is a British technology company focused on designing semiconductor chips and processors that power many different devices, from smartphones and tablets to servers in data...
Read more
Zobrazit další komentáře
I would love to have this stock in my portfolio, but I'm still waiting for a better price.
What do you think about $RHM.DEstock ?
For me, a quality company that is in an important sector and overall I like the focus and would like to have this sector represented in my portfolio. So I'll either buy $LMT or $RHM.DE, but I'll have to wait a while for a better price as both stocks are still pretty expensive.
Zobrazit další komentáře
I would love to buy their stock, but unfortunately the valuation is really high right now. I'll wait for a better price.
📈 CVS Health stock on the rise: strong results and changes in leadership!
CVS Health $CVS, one of America's largest providers of healthcare services and pharmacy products, posted strong quarterly results that beat analyst expectations. The result was a sharp rise in share value. The company's revenue increased by 6,3 % to an impressive $95.4 billion, while earnings per share...
Read more
Zobrazit další komentáře
The company has had one worse period, but I don't think that matters at all. I believe that next year the company will do well.
Goldman Sachs warns: Donald Trump will threaten the European economy